Work

O-0006 Dose Escalation to Rash for Erlotinib Plus Gemcitabine in Patients with Metastatic Pancreatic Cancer: The Phase II RACHEL (BO21128) Study

Year: 2012

Type: conference-abstract

Source: Annals of Oncology

DOI: 10.1016/s0923-7534(19)66471-9

Authors: Eric Van Cutsem, Elzbieta Nowara, Tudor Ciuleanu, Giuseppe Aprile, Malcolm Moore, Irena Federowicz, Jean Luc Van Laethem, Chiun Hsu, Sajid Ali, Zsuzsanna Csutor, Xianhua Meng, Chung-Pin Li

Institutions: Universitair Ziekenhuis Leuven, Institute of Oncology Prof. Dr. Ion Chiricuta, University of Udine, Princess Margaret Cancer Centre, Erasmus Hospital, National Taiwan University Hospital, Roche (United Kingdom), F. Hoffmann-La Roche AG, Roche (China), Taipei Veterans General Hospital, Centre Hospitalier Universitaire de Besançon, National Yang Ming University

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3000707262

Cites:

Cited by: 4

Related to: 10